Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Tobacco use, both active and passive, significantly influences the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Active smoking increases MASLD risk through mechanisms such as...
GLP-1 receptor agonists (GLP-1RAs) are medications commonly used to treat type 2 diabetes, obesity, and metabolic liver diseases. A meta-analysis of 55 randomized trials involving over 106,000 participants...
Autoantibodies, specifically ANA (antinuclear antibodies) and ASMA (anti-smooth muscle antibodies), are immune system proteins that mistakenly target the body’s own tissues. These autoantibodies were studied in patients with...
GLP-1 receptor agonists (GLP-1RAs) have emerged as a promising therapeutic option for type 2 diabetes mellitus (T2DM) due to their multifaceted benefits, including significant liver protection. Here is...
Two-dimensional shear wave elastography (2D-SWE) is a non-invasive imaging technique used to measure liver stiffness, which helps assess the severity of liver fibrosis. Liver fibrosis occurs when scar...
The new generation of non-invasive tests (NITs) for liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) are advanced diagnostic tools developed using machine learning and multitargeting approaches....
Targeting hepatic stellate cells (HSCs) in metabolic dysfunction-associated steatohepatitis (MASH) represents a promising therapeutic approach to prevent or reverse liver fibrosis, a key driver of disease progression. Below...
Plasma metabolomics, a branch of metabolomics focused on analyzing small molecules (metabolites) in blood plasma, plays a promising role in the prevention of metabolic dysfunction-associated steatohepatitis (MASH) and...
Exosome-related genes have gained significant attention for their potential role in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) to hepatocellular carcinoma (HCC)....
The study you provided investigates the relationship between normal ALT (alanine transaminase) levels, liver fibrosis, and metabolic dysfunction-associated steatotic liver disease (MASLD). Here's a detailed breakdown of the...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.